Acquiring Company
GE HealthCare
Acquired Company
Sofie Biosciences
ChicagoCulver CityOtherInformation TechnologyBiotechnologyHealth CareMedicalBiotechnologyDescription
GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences for $945 million in cash. This acquisition aims to establish a 'Final Mile' footprint for PET radiopharmaceutical supply in the U.S. The transaction is expected to close in the first half of 2027, pending regulatory approvals. SOFIE will become part of GE HealthCare’s PDx segment upon completion.
Fundz sees it the moment GE HealthCare makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sofie Biosciences?
Sofie Biosciences was acquired by GE HealthCare, based in Chicago. The deal was reported on October 5, 2026. GE HealthCare is publicly traded (GEHC) and operates in Other.
When did GE HealthCare acquire Sofie Biosciences?
GE HealthCare's acquisition of Sofie Biosciences was reported on October 5, 2026. GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences for $945 million in cash. This acquisition aims to establish a 'Final Mile' footprint for PET radiopharmaceutical supply in the U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sofie Biosciences do?
Sofie Biosciences focuses on the development of radiopharmaceuticals for medical imaging. It operates a network that manufactures radioactive materials used in PET scans. The company's product pipeline includes agents for detecting cancers. It is privately held, operating in Biotechnology, and is based in Culver City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.